VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $522,784 | -60.8% | 45,658 | -73.6% | 0.00% | -100.0% |
| Q1 2023 | $1,333,182 | +771.8% | 172,916 | +589.8% | 0.00% | – |
| Q4 2022 | $152,921 | +49.9% | 25,069 | +46.4% | 0.00% | – |
| Q2 2022 | $102,000 | -90.5% | 17,124 | -87.9% | 0.00% | – |
| Q1 2022 | $1,079,000 | +2816.2% | 141,570 | +934.3% | 0.00% | – |
| Q4 2021 | $37,000 | -70.6% | 13,687 | -22.2% | 0.00% | – |
| Q4 2020 | $126,000 | -40.6% | 17,595 | +43.0% | 0.00% | – |
| Q3 2019 | $212,000 | – | 12,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |